Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies | ||
| dc.conicet.organizacion | University of Pennsylvania | |
| dc.conicet.organizacion | H. Lee Moffitt Cancer Center | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | University of Pennsylvania | |
| dc.conicet.organizacion | University of Pennsylvania | |
| dc.conicet.organizacion | University of Pennsylvania | |
| dc.conicet.organizacion | H. Lee Moffitt Cancer Center | |
| dc.conicet.organizacion | H. Lee Moffitt Cancer Center | |
| dc.conicet.organizacion | H. Lee Moffitt Cancer Center | |
| dc.conicet.organizacion | University of Pennsylvania | |
| dc.conicet.organizacion | H. Lee Moffitt Cancer Center | |
| dc.contributor.author | Rosemblit, Cinthia | |
| dc.contributor.author | Datta, Jashodeep | |
| dc.contributor.author | Lowenfeld, Lea | |
| dc.contributor.author | Xu, Shuwen | |
| dc.contributor.author | Basu, Amrita | |
| dc.contributor.author | Kodumudi, Krithika | |
| dc.contributor.author | Wiener, Doris | |
| dc.contributor.author | Czerniecki, Brian J. | |
| dc.date.issued | 2018-04 | |
| dc.description.abstract | In patients with HER2-expressing breast cancer many develop resistance to HER2 targeted therapies. We show that high and intermediate HER2-expressing cancer cell lines are driven toward apoptosis and tumor senescence when treated with either CD4+ Th1 cells, or Th1 cytokines TNF-α and IFN-γ, in a dose dependent manner. Depletion of HER2 activity by either siRNA or trastuzumab and pertuzumab, and subsequent treatment with either anti-HER2 Th1 cells or TNF-α and IFN-γ resulted in synergistic increased tumor senescence and apoptosis in cells both sensitive and cells resistant to trastuzumab which was inhibited by neutralizing anti-TNF-α and IFN-γ. Th1 cytokines induced minimal senescence or apoptosis in triple negative breast cancer cells (TNBC); however, inhibition of EGFR in combination with Th1 cytokines sensitized those cells causing both senescence and apoptosis. TNF-α and IFN-γ led to increased Stat1 phosphorylation through serine and tyrosine sites and a compensatory reduction in Stat3 activation. Single agent IFN-γ enhanced Stat1 phosphorylation on tyrosine 701 and similar effects were observed in combination with TNF-α and EGFR inhibition. These results demonstrate Th1 cytokines and antioncodriver blockade cooperate in causing tumor senescence and apoptosis in TNBC and HER2-expressing breast cancer, suggesting these combinations could be explored as non-cross-reactive therapy preventing recurrence in breast cancer. | es |
| dc.description.fil | Fil: Rosemblit, Cinthia. H. Lee Moffitt Cancer Center; Estados Unidos. University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Datta, Jashodeep. University of Pennsylvania; Estados Unidos | |
| dc.description.fil | Fil: Lowenfeld, Lea. University of Pennsylvania; Estados Unidos | |
| dc.description.fil | Fil: Xu, Shuwen. University of Pennsylvania; Estados Unidos | |
| dc.description.fil | Fil: Basu, Amrita. H. Lee Moffitt Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Kodumudi, Krithika. H. Lee Moffitt Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Wiener, Doris. H. Lee Moffitt Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Czerniecki, Brian J.. H. Lee Moffitt Cancer Center; Estados Unidos. University of Pennsylvania; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Rosemblit, Cinthia; Datta, Jashodeep; Lowenfeld, Lea; Xu, Shuwen; Basu, Amrita; et al.; Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies; Impact Journals; Oncotarget; 9; 33; 4-2018; 23058-23077 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1949-2553 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/103583 | |
| dc.journal.ciudad | Albany | es |
| dc.journal.number | 33 | es |
| dc.journal.pagination | 23058-23077 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Oncotarget | es |
| dc.journal.volume | 9 | es |
| dc.language.iso | eng | es |
| dc.publisher | Impact Journals | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pubmed/29796172 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.18632/oncotarget.25208 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.oncotarget.com/article/25208/text/ | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | * |
| dc.subject | CD4+ T-HELPER IMMUNITY | es |
| dc.subject | HER2/NEU | es |
| dc.subject | TRIPLE NEGATIVE | es |
| dc.subject | BREAST CANCER | es |
| dc.subject.classification | Bioquímica y Biología Molecular | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.b34a31d8-e5c4-41a5-9b03-4a01b77b480a_A.pdf
- Tamaño:
- 7.48 MB
- Formato:
- Adobe Portable Document Format